STE — STERIS plc (Ireland) stock price and chart

Share this page

STE

$209.68+0.49%

as of close, Oct 7, 2026

☾ AH $209.68 +0.49%

STERIS plc (Ireland)Stock · HealthcareS&P 500 Equal Weight 0.2%S&P 500 0.03%US Stock Market 0.03%Russell 3000 0.03%

PeersMRNALLYUNHJNJMDTMRK

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEEDEDED

20162019202120242026

80.0100.0120.0140.0160.0180.0200.0220.0240.0260.0010.0M$209.68

2026-10-07

Price$209.68

MA20$217.49

MA50$234.49

Vol3.1M

What would $1,000 invested in STE be worth today? →

STE returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $209.68
YTD price return: -17.29%
YTD total return: -16.58%
Next earnings: Nov 4, 2026
Market cap: 20.4B2017-03 6B2026-10 20.4B+241.9% over the window
Enterprise value: 22B
Shares outstanding: 97.5M2017-03 86.1M2026-06 97.5M+13.2% over the window
52W low: $195.14
52W high: $269.44
From 52W high: -22.18%
From 52W low: +7.45%
52W range: 20%
Beta: 0.91

Volume

Rel volume: 1.03×
30D volume: 652.9K
30D $ vol: 140.1M

Insider trading

Insider net 1WNo open-market insider purchase or sale with a transaction date in the last 7 days, as filed on Form 4.: none
Insider net 1MNo open-market insider purchase or sale with a transaction date in the last 30 days, as filed on Form 4.: none
Insider net 3M0 insider-days of buying (no priced lot) and 1 of selling ($957K) in the last 91 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.: −$957K
Insider net 1Y0 insider-days of buying (no priced lot) and 6 of selling ($3.2M) in the last 365 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.: −$3.2M

Form 4 transactions by trade date, as filed; latest on file 2026-08-12.

Fundamentals

Sales (ttm): 6B2017-03 2.6B2026-06 6B+131.1% over the window
Sales/share: $61.922017-03 $30.352026-06 $61.92+104.0% over the window
EPS (ttm): $8.182017-03 $1.282026-06 $8.18+539.0% over the window
FCF (ttm): 925.6M2017-03 251.2M2026-06 925.6M+268.5% over the window
FCF/share: $9.492017-03 $2.922026-06 $9.49+225.4% over the window
Book value/share: $73.912017-03 $32.642026-06 $73.91+126.5% over the window
Net margin: 13.33%2017-03 4.2%2026-06 13.3%+216.8% over the window
ROE: 11.17%2017-03 3.9%2026-06 11.2%+185.5% over the window
ROA: 7.50%2018-03 5.6%2026-06 7.5%+34.1% over the window
Debt / equity: 0.23×2018-03 0.412026-06 0.23-44.2% over the window
Current ratio: 1.912018-03 2.482026-06 1.91-23.3% over the window

Growth (CAGR, ttm) · 10Y

Sales: +8.38%2025-06-30 → 2026-06-305.6B → 6B (+8.4% total)+8.95%2023-06-30 → 2026-06-304.7B → 6B (+29.3% total)+12.13%2021-06-30 → 2026-06-303.4B → 6B (+77.2% total)n/a
Net income: +24.55%2025-06-30 → 2026-06-30646.5M → 805.1M (+24.5% total)+88.94%2023-06-30 → 2026-06-30119.3M → 805.1M (+574.7% total)+23.00%2021-06-30 → 2026-06-30286M → 805.1M (+181.5% total)n/a
FCF: +1.85%2025-06-30 → 2026-06-30908.8M → 925.6M (+1.8% total)+23.30%2023-06-30 → 2026-06-30493.7M → 925.6M (+87.5% total)+16.89%2021-06-30 → 2026-06-30424.1M → 925.6M (+118.2% total)n/a
Shares: -1.01%2025-06-30 → 2026-06-3098.5M → 97.5M (-1.0% total)-0.43%2023-06-30 → 2026-06-3098.8M → 97.5M (-1.3% total)-0.46%2021-06-30 → 2026-06-3099.8M → 97.5M (-2.3% total)n/a

Per-share growth (CAGR, ttm) · 10Y

EPS: +25.18%2025-06-30 → 2026-06-30$6.54 → $8.18 (+25.2% total)+88.54%2023-06-30 → 2026-06-30$1.22 → $8.18 (+570.5% total)+19.62%2021-06-30 → 2026-06-30$3.34 → $8.18 (+144.9% total)n/a
Sales/share: +9.48%2025-06-30 → 2026-06-30$56.56 → $61.92 (+9.5% total)+9.43%2023-06-30 → 2026-06-30$47.26 → $61.92 (+31.0% total)+12.64%2021-06-30 → 2026-06-30$34.15 → $61.92 (+81.3% total)n/a
FCF/share: +2.89%2025-06-30 → 2026-06-30$9.23 → $9.49 (+2.9% total)+23.84%2023-06-30 → 2026-06-30$5.00 → $9.49 (+89.9% total)+17.43%2021-06-30 → 2026-06-30$4.25 → $9.49 (+123.3% total)n/a
Book value/share: +4.64%2025-06-30 → 2026-06-30$70.64 → $73.91 (+4.6% total)+5.78%2023-06-30 → 2026-06-30$62.44 → $73.91 (+18.4% total)+2.32%2021-06-30 → 2026-06-30$65.90 → $73.91 (+12.2% total)n/a
Dividend/share: +10.53%2025-06-30 → 2026-06-30$2.28 → $2.52 (+10.5% total)+10.26%2023-06-30 → 2026-06-30$1.88 → $2.52 (+34.0% total)+9.51%2021-06-30 → 2026-06-30$1.60 → $2.52 (+57.5% total)n/a
Price: -13.21%2025-10-07 → 2026-10-07$241.56 → $209.68 (-13.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-2.21%2023-10-06 → 2026-10-07$224.23 → $209.68 (-6.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-0.71%2021-10-07 → 2026-10-07$217.33 → $209.68 (-3.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+11.28%2016-10-06 → 2026-10-07$71.99 → $209.68 (+191.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: -12.46%2025-10-07 → 2026-10-07$239.50 → $209.68 (-12.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-1.29%2023-10-06 → 2026-10-07$217.99 → $209.68 (-3.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+0.21%2021-10-07 → 2026-10-07$207.52 → $209.68 (+1.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+12.43%2016-10-06 → 2026-10-07$64.95 → $209.68 (+222.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 25.6×2017-03 54.382026-10 25.39-53.3% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 17.9×2017-03 26.442026-10 17.91-32.3% over the window
Fwd P/E: 17.0×
P/S (ttm)Market cap ÷ TTM revenue.: 3.4×2017-03 2.292026-10 3.39+47.9% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 2.8×2017-03 2.132026-10 2.84+33.3% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 22.1×2017-03 23.812026-10 22.09-7.2% over the window
EV/EBITDA (fy): 13.5×
EV/Sales (ttm): 3.6×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 4.53%2017-03 4.2%2026-06 4.5%+7.7% over the window
Dividend yield (fwd)Indicated annual dividend ÷ last close: the last regular payment × payments a year, from our own dividend record. Shown only for a company that pays the same amount each time (raises and cuts allowed), whose payments are on schedule and agree with the dividends it reports paying; a company whose payments vary in size, such as an unequal interim and final, has no forward figure — see the ttm yield.: 1.32%
Dividend/share (fwd)The indicated annual dividend: the last regular payment × payments a year, for a company that pays the same amount each time.: $2.76
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 97.5M ÷ 98.5M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 1.01%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (1.01%) + dividends paid over that year ($247M) ÷ market_cap_at(2025-06-30) ($23.7B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 2.05%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($340.4M) ÷ today's market cap ($20.4B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 1.67%2017-03 1.6%2026-06 1.7%+2.0% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $340.4M + TTM dividends $247M) ÷ today's market cap ($20.4B). Same caveat as the cash buyback yield.: 2.87%2017-03 3.2%2026-06 2.9%-10.0% over the window

Vs own 10Y history

P/E: 1st
P/OI: 6th
P/S: 7th
P/B: 8th
P/FCF: 3rd

Bar = where today’s multiple sits in STE’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-07#

+0.49%

-0.16%

-6.64%

-2.65%

YTD

-17.29%

-13.20%

-3.52%

Recent filings#

Aug 12Insider sale · Sohi Mohsen (Director) sold 4,058 shares for $957K at $235.78
Aug 5Earnings · Earnings release — EPS $2.59 vs $2.54 est. (+2.0%); revenue $1.49B (+7% y/y) 0.4%

All filings and insider trades →

Financial statements

Open full STE financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+3.42%	+2.70%
JNJ	Johnson & Johnson	-6.10%	+1.44%
ABBV	AbbVie Inc.	+5.81%	+1.75%
MRK	Merck & Co. Inc.	-5.02%	+0.60%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	-5.33%	-0.09%
TMO	Thermo Fisher Scientific Inc.	+7.87%	+0.83%
AMGN	Amgen Inc.	-5.52%	+2.60%
GILD	Gilead Sciences Inc.	-2.75%	+1.82%

STE — STERIS plc (Ireland) price, chart and key statistics